High-dose granulocyte-colony stimulating factor promotes neointimal hyperplasia in the early phase and inhibits neointimal hyperplasia in the late phase after vascular injury

Circulation Journal

Volumn 72, Issue 11, 2008, Pages 1885-1893

  Shoji, Makoto ^a   Iso, Yoshitaka ^a   Kusuyama, Taro ^a   Omori, Yasutoshi ^a   Soda, Teruko ^a   Tsunoda, Fumiyoshi ^a   Sato, Takatoshi ^a   Koba, Shinji ^a   Geshi, Eiichi ^a   Kobayashi, Youichi ^a   Katagiri, Takashi ^a   Suzuki, Hiroshi ^b  

^a SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SHOWA UNIVERSITY FUJIGAOKA HOSPITAL   (Japan)

Author keywords

Bone marrow derived cell; CD34; G CSF; Neointima; Re endothelialization

Indexed keywords

ATAXIN 1; CD34 ANTIBODY; GRANULOCYTE COLONY STIMULATING FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTERY WALL; ARTICLE; BLOOD VESSEL INJURY; BONE MARROW CELL; BONE MARROW CULTURE; CONTROLLED STUDY; DRUG MEGADOSE; EPITHELIUM HYPERPLASIA; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NICK END LABELING; NONHUMAN; SMOOTH MUSCLE FIBER; STEM CELL;

ANIMALS; ANTIGENS, CD34; ANTIGENS, LY; CELL PROLIFERATION; FEMORAL ARTERY; GRANULOCYTE COLONY-STIMULATING FACTOR; HYPERPLASIA; INFLAMMATION; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; STEM CELLS; TUNICA INTIMA;

EID: 55449129411     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-07-1037     Document Type: Article

References (27)

1. Ross R. Atherosclerosis: An inflammatory disease. N Engl J Med 1999; 340: 115-126.
2. Moreno R, Fernandez C, Hernandez R, Alfonso F, Angiolillo DJ, Sabate M, et al. Drug-eluting stent thrombosis: Results from a pooled analysis including 10 randomized studies. J Am Coll Cardiol 2005; 45: 954-959.
3. Orlic D, Kajstura J, Chimenti S, Limana F, Jakoniuk I, Quaini F, et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci USA 2001; 98: 10344-10349.
4. Minatoguchi S, Takemura G, Chen XH, Wang N, Uno Y, Koda M, et al. Acceleration of the healing process and myocardial regeneration may be important as a mechanism of improvement of cardiac function and remodeling by postinfarction granulocyte colony-stimulating factor treatment. Circulation 2004; 109: 2572-2580.
5. Maekawa Y, Anzai T, Yoshikawa T, Sugano Y, Mahara K, Kohno T, et al. Effect of granulocyte-macrophage colony-stimulating factor inducer on left ventricular remodeling after acute myocardial infarction. J Am Coll Cardiol 2004; 44: 1510-1520.
6. Wollert KC, Meyer GP, Lotz J, Ringers-Lichtenberg S, Lippolt P, Breidenbach C, et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: The BOOST randomized controlled clinical trial. Lancet 2004; 364: 141-148.
7. Suzuki K, Nagashima K, Arai M, Uno Y, Misao Y, Takemura G, et al. Effect of granulocyte colony-stimulating factor treatment at a low dose but for a long duration in patients with coronary heart disease. Circ J 2006; 70: 430-437.
8. Hasegawa H, Takano H, Shiraishi H, Ueda K, Niitsuma Y, Tadokoro H, et al. Intracolony injection of granulocyte colony-stimulating factor ameliorates the progression of left ventricular remodeling after myocardial ischemia/reperfusion in rabbits. Circ J 2006; 70: 942-944.
9. Kong D, Melo LG, Gnecchi M, Zhang L, Mostoslavsky G, Liew CC, et al. Cytokine-induced mobilization of circulating endothelial progenitor cells enhances repair of injured arteries. Circulation 2004; 110: 2039-2046.
10. Kang HJ, Kim H, Zhang S, Park K, Cho H, Koo B, et al. Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: The MAGIC cell randomized clinical trial. Lancet 2004; 363: 751-756.
11. Yoshioka T, Takahashi M, Shiba Y, Suzuki C, Morimoto H, Izawa A, et al. Granulocyte colony-stimulating factor (G-CSF) accelerates reendothelialization and reduces neointimal formation after vascular injury. Cardiovasc Res 2006; 70: 61-69.
12. + progenitor cells regenerate endothelium and inhibit neointimal hyperplasia after vascular injury. Arterioscler Thromb Vasc Biol 2006; 26: 751-757.
13. Sata M, Maejima Y, Adachi F, Fukino K, Saiura A, Sugiura S, et al. A mouse model of vascular injury that induces rapid onset of medial cell apoptosis followed by reproducible neointimal hyperplasia. J Mol Cell Cardiol 2000; 32: 2097-2104.
14. Okada S, Yoshida T, Hong Z, Ishii G, Hatano M, Kuro-o M, et al. Impairment of B lymphopoiesis in precocious aging (klotho) mice. Int Immunol 2000; 12: 861-871.
15. Sato T, Suzuki S, Shibata M, Kusuyama T, Omori Y, Soda T, et al. Tumor necrosis factor α gene deficient mice have improved cardac function through reduction of intracellular adhesion molecule-1 in myocardial infarction. Circ J 2006; 70: 1635-1642.
16. Shoji M, Sata M, Fukuda D, Tahaka K, Sato T, Iso Y, et al. Temporal and spatial characterization of cellular constituents during neointimal hyperplasia after vascular injury: Potential contribution of bone marrow derived progenitors to arterial remodeling. Cardiovasc Pathol 2004; 13: 306-312.
17. Tanaka K, Sata M, Hirata Y, Nagai R. Diverse contribution of bone marrow cells to neointimal hyperplasia after mechanical vascular injuries. Circ Res 2003; 93: 783-790.
18. Simper D, Stalboerger PG, Panetta CJ, Wang S, Caplice NM. Smooth muscle progenitor cells in human blood. Circulation 2002; 106: 1199-1204.
19. Soda T, Suzuki H, Iso Y, Kusuyama T, Omori Y, Sato T, et al. Bone marrow cells contribute to neointimal formation after stent implantation in swine. Int J Cardiol 2007; 121: 44-52.
20. Hasegawa H, Takano H, Ohtsuka M, Ueda K, Niitsuma Y, Qin Y, et al. G-CSF prevents the progression of atherosclerosis and neointimal formation in rabbits. Biochem Biophys Res Commun 2006; 344: 370-376.
21. Harada M, Qin Y, Takano H, Minamino T, Zou Y, Toko H, et al. G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes. Nat Med 2005; 11: 305-311.
22. Hill JM, Syed MA, Arai AE, Powell TM, Paul JD, Zalos G, et al. Outcomes and risks of granulocyte colony-stimulating factor in patients with coronary artery disease. J Am Coll Cardiol 2005; 46: 1643-1648.
23. Saiura A, Sata M, Hirata Y, Nagai R, Makuuchi M. Circulating smooth muscle progenitor cells contribute to atherosclerosis. Nat Med 2001; 7: 382-383.
24. Sata M, Saiura A, Kunisato A, Tojo A, Okada S, Tokuhisa T, et al. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med 2002; 8: 403-409.
25. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, et al. Isolation of putative endothelial cells for angiogenesis. Science 1997; 275: 964-967.
26. Kajstura J, Rota M, Whang B, Cascapera S, Hosoda T, Bearzi C, et al. Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion. Circ Res 2005; 96: 127-137.
27. Lapidot T, Petit I. Current understanding of stem cell mobilization the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells. Exp Hematol 2002; 30: 973-981.